Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2018 08:00 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals Initiates Phase I Clinical Study on its Oral Drug Candidate Derived from Cannabidiol

SAN DIEGO, CA, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced the initiation of enrollment...
September 24, 2018 08:00 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals Announces Publications on Patented Cannabinoid Derivatives to Treat Scleroderma and Amyotrophic Lateral Sclerosis

Preclinical data published in Biochemical Pharmacology and British Journal of Pharmacology highlight neuroprotective, anti-fibrotic, and anti-inflammatory effects SAN DIEGO, CA, Sept. 24, 2018 ...
August 28, 2018 08:00 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

San Diego, CA, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced that Jim DeMesa, MD, Chief...